 | TCR2 Therapeutics Inc. (NASDAQ:TCRR) Sees Significant Decrease in Short Interest
americanbankingnews.com - June 18 at 8:20 AM |
| Traders Buy Large Volume of TCR2 Therapeutics Put Options (NASDAQ:TCRR)
americanbankingnews.com - June 11 at 7:04 AM |
| TCR2 Therapeutics Inc. (NASDAQ:TCRR) Expected to Post Earnings of -$0.60 Per Share
americanbankingnews.com - June 5 at 7:18 PM |
| TCR2 Therapeutics Inc. (NASDAQ:TCRR) Given Consensus Recommendation of "Buy" by Brokerages
americanbankingnews.com - June 2 at 1:38 AM |
 | TCR² Therapeutics to Participate in Two Upcoming Conferences in June
finance.yahoo.com - May 26 at 10:12 AM |
| TCR² Therapeutics to Present at the Truist Securities Life Sciences Summit
finance.yahoo.com - April 29 at 8:32 AM |
| Companies Like TCR2 Therapeutics (NASDAQ:TCRR) Are In A Position To Invest In Growth
finance.yahoo.com - April 27 at 3:07 PM |
| TCRR May 2021 20.000 call
ca.finance.yahoo.com - April 23 at 12:06 AM |
| TCR² Highlights Gavo-cel Translational Data and Emerging Solid Tumor Pipeline Preclinical Data at AACR Annual Meeting
finance.yahoo.com - April 10 at 1:22 PM |
| TCR² Therapeutics to Present at the Needham Healthcare Conference
finance.yahoo.com - April 8 at 7:11 AM |
|
| TCRR Jul 2021 35.000 call
ca.finance.yahoo.com - April 7 at 7:36 AM |
| TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility
finance.yahoo.com - March 29 at 8:22 AM |
| TCR² Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - March 11 at 9:13 AM |
| TCR² Presentations at American Association of Cancer Research (AACR) Annual Meeting 2021 to Highlight Solid Tumor Pipeline
finance.yahoo.com - March 10 at 7:13 PM |
| TCR² Therapeutics to Participate in Two Upcoming Conferences in March
finance.yahoo.com - March 3 at 8:26 AM |
 | TCR(2) Therapeutics to Present at SVB Leerink Global Healthcare Conference
marketwatch.com - February 17 at 2:16 PM |
| TCR² Therapeutics to Present at SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 17 at 9:15 AM |
| TCR² Therapeutics Announces Commercial Cell Therapy Leader Shawn Tomasello Joins its Board of Directors
finance.yahoo.com - February 4 at 9:47 AM |
| TCR² Therapeutics Announces Pricing of Public Offering of $140.0 Million of Common Stock
finance.yahoo.com - January 19 at 11:44 PM |
| Kazia Therapeutics Limited (KZIA)
finance.yahoo.com - January 16 at 8:20 PM |
| TCR² Therapeutics Announces 2021 Strategic Priorities and Milestones
finance.yahoo.com - January 8 at 3:19 PM |
| TCR(2) Therapeutics to Present at J.P. Morgan Healthcare Conference
marketwatch.com - December 21 at 1:03 PM |
| TCR² Therapeutics to Present at J.P. Morgan Healthcare Conference
finance.yahoo.com - December 21 at 1:03 PM |
 | Thinking about buying stock in Tcr2 Therapeutics, Inovio Pharmaceuticals, BioLineRx, Plug Power, or Arbutus Biopharma?
benzinga.com - December 17 at 10:10 PM |
| Is TCRR A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 3:25 PM |
| TCR² Announces RECIST Response in Ovarian Cancer from Ongoing Phase 1/2 Trial of TC-210 in Treatment Refractory Mesothelin-Expressing Solid Tumors
finance.yahoo.com - December 13 at 2:56 PM |
| TCR² Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - November 12 at 7:37 AM |
| TCR² Therapeutics Announces Partnership with ElevateBio to Expand TC-210 Manufacturing Capacity
finance.yahoo.com - November 10 at 8:43 AM |
|
| What Type Of Shareholders Own The Most Number of TCR2 Therapeutics Inc. (NASDAQ:TCRR) Shares?
finance.yahoo.com - October 27 at 2:13 PM |
| Piper Sandler: These 2 Healthcare Stocks Could Be the Next M&A Target
finance.yahoo.com - October 18 at 7:02 AM |
| TCR2 Therapeutics Inc. (2K7.F)
in.finance.yahoo.com - October 12 at 9:29 AM |
 | TCR² Therapeutics to Present at Jefferies Cell Therapy Virtual Summit
markets.businessinsider.com - September 29 at 8:35 AM |
| TCR2 Therapeutics to Participate in Two Upcoming Conferences in September
finance.yahoo.com - September 8 at 12:07 PM |
 | TCR2 Therapeutics EPS misses by $0.03
seekingalpha.com - August 12 at 10:05 AM |
| TCR² Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - August 12 at 10:05 AM |
| Why TCR2 Therapeutics Is Soaring Today
finance.yahoo.com - July 27 at 4:54 PM |
| TCR² Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - July 27 at 4:54 PM |
| Stock Alert: TCR2 Therapeutics Up 35%
markets.businessinsider.com - July 27 at 11:53 AM |
| TCR2 Therapeutics Releases Positive Solid Tumor Data
finance.yahoo.com - July 27 at 11:53 AM |
| TCR2 Therapeutics' TC-210 successful in mid-stage cancer study
seekingalpha.com - July 27 at 6:53 AM |
| We're Not Very Worried About TCR2 Therapeutics' (NASDAQ:TCRR) Cash Burn Rate
finance.yahoo.com - July 27 at 6:53 AM |
| TCR² Therapeutics to announce interim data from its lead drug's early-stage study
seekingalpha.com - July 26 at 10:44 PM |
| TCR² Therapeutics Announces RECIST Responses with First TC-210 Dose Tested in Advanced Mesothelin-Expressing Solid Tumors
finance.yahoo.com - July 26 at 5:43 PM |
| TCR² Therapeutics to Announce Interim Data from Phase 1/2 Clinical Trial of TC-210 in Mesothelin-Expressing Solid Tumors
finance.yahoo.com - July 24 at 6:30 PM |
| TCR² Therapeutics to Present at the BMO Prescriptions for Success Healthcare Conference
finance.yahoo.com - June 17 at 8:23 AM |
| Hedge Funds Have Never Been This Bullish On TCR2 Therapeutics Inc. (TCRR)
finance.yahoo.com - June 15 at 12:10 AM |
 | TCR2 Therapeutics Inc (TCRR.OQ)
in.reuters.com - June 8 at 10:56 PM |
| TCR² Therapeutics Hires Key Business Development and Regulatory Affairs Cell Therapy Experts to Support Strategic Objectives
finance.yahoo.com - May 27 at 10:07 AM |
| TCR2 Therapeutics EPS beats by $0.76
seekingalpha.com - May 14 at 10:34 AM |
| TCR² Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - May 14 at 10:34 AM |
